Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2008
04/24/2008WO2008047843A1 Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit
04/24/2008WO2008047842A1 Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit
04/24/2008WO2008047799A1 Immunological analysis reagent and immunological analysis method
04/24/2008WO2008047798A1 Method of producing polymer microparticles
04/24/2008WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody
04/24/2008WO2008047574A1 Sensitizer for anticancer agent
04/24/2008WO2008047533A1 Microchip reaction detection system, and method of reaction of microchip in flow path
04/24/2008WO2008047485A1 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator
04/24/2008WO2008047370A2 Compositions and methods for inducing angiogenesis
04/24/2008WO2008047364A2 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
04/24/2008WO2008047159A1 A fluid monitoring apparatus and a method of operating the same
04/24/2008WO2008047129A2 Latent fluorescent probes
04/24/2008WO2008047115A1 Gas sensor
04/24/2008WO2008047095A1 Method
04/24/2008WO2008047086A2 Biomarker
04/24/2008WO2008046964A2 Novel useful inhibitors
04/24/2008WO2008046948A2 Method for the comparative quantitative analysis of proteomes by means of stable isotopic labelling and mass spectrometry
04/24/2008WO2008046826A1 Machine tool and/or production machine
04/24/2008WO2008046665A2 Method for identifying urotensin 2 convertase inhibitors
04/24/2008WO2008046650A1 Novel method for treating h.pylori infections
04/24/2008WO2008046630A1 Devices for and methods of monitoring a parameter of a fluidic sample by microdialysis
04/24/2008WO2008046543A1 Cell protective genes
04/24/2008WO2008046517A1 Ctgf as a biomarker, therapeutic and diagnostic target
04/24/2008WO2008046512A1 Prss23 as a biomarker, therapeutic and diagnostic target
04/24/2008WO2008046511A1 Crtac as a biomarker, therapeutic and diagnostic target
04/24/2008WO2008046419A1 A device for the use in permeability testing of containers
04/24/2008WO2008046376A1 Method for measuring the consistency of rye dough
04/24/2008WO2008046292A1 Analysis method for 5-differential complete blood cell based on visual image
04/24/2008WO2008046213A1 Measuring multiple analytes over a broad range of concentrations using optical diffraction
04/24/2008WO2008046189A1 Proteins involved in after-cooking darkening in potatoes
04/24/2008WO2008046182A1 Stroma derived predictor of breast cancer
04/24/2008WO2008046160A1 Assay for the detection of biomarkers associated with pregnancy related conditions
04/24/2008WO2008046136A1 Sorting mined material
04/24/2008WO2008046125A1 Method for determining ace2 activity
04/24/2008WO2008029085A3 Polymerase
04/24/2008WO2008025564A3 Methods for detecting protein-peptide interactions
04/24/2008WO2008022205A3 Thyroxine-containing compound analysis methods
04/24/2008WO2008021263A3 Methods of indentifying antibodies that bind oligomeric forms of chemokines and uses thereof
04/24/2008WO2008020851A3 Nanoarrays of single virus particles, methods and instruments for the fabrication and use thereof
04/24/2008WO2008020365A3 Magnetic sensor device
04/24/2008WO2008017928A3 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome
04/24/2008WO2008015425A3 Mhc oligomers, components thereof, and methods of making the same
04/24/2008WO2008009857A3 Modulators of udp-glucose ceramide glucosyltransferase in the treatment of acne or of hyperkeratinization
04/24/2008WO2008007242A3 Increased specificity of analyte detection by measurement of bound and unbound labels
04/24/2008WO2008006554A3 Glyco-engineered antibodies
04/24/2008WO2008003365A3 Capacitive measuring device for detecting foreign substances in a liquid
04/24/2008WO2007149935A3 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
04/24/2008WO2007149281A3 Combinatorial library for proteomic investigations
04/24/2008WO2007146334A3 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
04/24/2008WO2007140843A3 Assay for the diagnosis of alzheimer's disease based on the determination of the ratio of gamma-secretase abeta cleavage products
04/24/2008WO2007126725A3 Systems and methods of combinatorial synthesis
04/24/2008WO2007123579B1 Translational dysfunction based therapeutics
04/24/2008WO2007100506A3 Mass tags for quantitative analyses
04/24/2008WO2007098213A3 Oil monitoring system
04/24/2008WO2007089731A3 Ocular fluid markers
04/24/2008WO2007081768A3 Use of he4 and other biochemical markers for assessment of ovarian cancers
04/24/2008WO2007081767A3 Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
04/24/2008WO2006110356A3 Method for on-line fuel-dilution monitoring of engine lubricant
04/24/2008US20080097940 Kernels and kernel methods for spectral data
04/24/2008US20080097737 Apparatus and method for coding genetic information
04/24/2008US20080097735 System for predicting changes in a drilling event during wellbore drilling prior to the occurrence of the event
04/24/2008US20080097653 Computer Controlled Fertigation System and Method
04/24/2008US20080097180 Diabetes care management system
04/24/2008US20080097170 Blood glucose monitoring system
04/24/2008US20080097115 An oligonucleotide having a free 3' or 5'-amino group silylated to DNA intermediate; immobilizating silylated oligonucleotides or proteins
04/24/2008US20080097090 Functional and hyperfunctional siRNA directed against Bcl-2
04/24/2008US20080097084 Rho Antibody And Tag To Purify Cell Surface Proteins
04/24/2008US20080097083 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone
04/24/2008US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia
04/24/2008US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1
04/24/2008US20080096892 C-Kit Modulators And Methods Of Use
04/24/2008US20080096836 Contacting sample of heterogenous protein from blood, lymph or cerebrospinal fluid or protein expression library such as a wound site-, a lambda wound site expression-, or a phage display library with compound from saliva or salivary glands of a blood-feeding parasite; isolating ligand or receptor
04/24/2008US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering
04/24/2008US20080096821 Cytostatin II
04/24/2008US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease
04/24/2008US20080096289 Self assambling monolayer of microscrystals for ehnancing light scattering during raman spectroscopy
04/24/2008US20080096288 Membrane-based assay devices
04/24/2008US20080096287 Dispensing nanoparticle structures on to solid support; seeding/immobilizing nucleotide sequences on surface
04/24/2008US20080096286 Using spectral profile of peptides as diagnostic tool in detection of cardiovascular disorders
04/24/2008US20080096284 Reverse phase liquid chromatography; mass spectrometry
04/24/2008US20080096283 Methods for detection of breast cancer
04/24/2008US20080096282 Spectrophotometic Analysis of Plasma in a Closed-Container
04/24/2008US20080096281 Cyanide Sensing Compounds and Uses Thereof
04/24/2008US20080096280 Preparing oil in water emulsion by mixing with surfactant,adding ethene generator substrate and oxidative radical peroxyl solution (formed by thermolysis of 2,2'-Azobis(2-amidinopropane)dihydrochloride), measuring ethene produced via atmospheric chemical ionisation
04/24/2008US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
04/24/2008US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation
04/24/2008US20080096237 Using immunoglobulin specific to H11 kinase mutant as evaluative tool in detection and diagnosis of cell proliferative disorders
04/24/2008US20080096236 Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof
04/24/2008US20080096235 Biomarkers For Cancer Sensitivity And Uses Thereof
04/24/2008US20080096234 Using distribution of GlcNAc-6-sulfotransferase isozymes, sulfation enzymes of sugar residues, between non-carcinoma and carcinoma tissues as evaluative tools in prediciting cell proliferative disordrers
04/24/2008US20080096233 Using column chromatography to identify antibody/antigen binding elements; diagnosing infection, cell proliferative, liver, autoimmune and rheumatic diseases
04/24/2008US20080096232 Methods for the detection and diagnosis of Trypanosoma cruzi infection
04/24/2008US20080096231 Measuring circulating free drug in patient using differentially labeled antibodies and flow cytometry
04/24/2008US20080096230 Methods for assaying percentage of glycated hemoglobin
04/24/2008US20080096229 Filamentous receptor structure comprising D3 domain for use as components of elements
04/24/2008US20080096228 Using lymphocyte enhancer factor-1 (LEF-1) expression as evaluative tool in diagnosing cell proliferative disorders
04/24/2008US20080096227 Identifying agonist/antagonist of calcium release activated Ca+2 (CRAC) channel via variation in membrane premeability
04/24/2008US20080096226 Using phosphorylated signal transducer and activator of transcription 5 (Stat5) profile as evaluative tool in prognosticating efficay of antitumor treatments
04/24/2008US20080096225 Assays for detecting modulators of cytoskeletal function
04/24/2008US20080096224 Fusion proteins comprising pleckstrin homology domain of Akt (protein kinase B) and a pseudoligand containing acidic amino acid residues, sandwiched between resonance energy transfer (RET) pairs, such as cyan and yellow mutants of green fluorescent protein; high throughput assay; drug screening